224 related articles for article (PubMed ID: 27034474)
21. In vitro oxidized HDL and HDL from type 2 diabetes patients have reduced ability to efflux oxysterols from THP-1 macrophages.
Chen Y; Arnal-Levron M; Hullin-Matsuda F; Knibbe C; Moulin P; Luquain-Costaz C; Delton I
Biochimie; 2018 Oct; 153():232-237. PubMed ID: 29704538
[TBL] [Abstract][Full Text] [Related]
22. Influence of high density lipoprotein cholesterol levels on circulating monocytic angiogenic cells functions in individuals with type 2 diabetes mellitus.
Lucchesi D; Popa SG; Sancho V; Giusti L; Garofolo M; Daniele G; Pucci L; Miccoli R; Penno G; Del Prato S
Cardiovasc Diabetol; 2018 Jun; 17(1):78. PubMed ID: 29866130
[TBL] [Abstract][Full Text] [Related]
23. Diminished rate of mouse peritoneal macrophage cholesterol efflux is not related to the degree of HDL glycation in diabetes mellitus.
Passarelli M; Shimabukuro AF; Catanozi S; Nakandakare ER; Rocha JC; Carrilho AJ; Quintão EC
Clin Chim Acta; 2000 Nov; 301(1-2):119-34. PubMed ID: 11020467
[TBL] [Abstract][Full Text] [Related]
24. Apolipoprotein M predicts pre-beta-HDL formation: studies in type 2 diabetic and nondiabetic subjects.
Plomgaard P; Dullaart RP; de Vries R; Groen AK; Dahlbäck B; Nielsen LB
J Intern Med; 2009 Sep; 266(3):258-67. PubMed ID: 19457058
[TBL] [Abstract][Full Text] [Related]
25. HDL Cholesterol Efflux Predicts Graft Failure in Renal Transplant Recipients.
Annema W; Dikkers A; de Boer JF; Dullaart RP; Sanders JS; Bakker SJ; Tietge UJ
J Am Soc Nephrol; 2016 Feb; 27(2):595-603. PubMed ID: 26319244
[TBL] [Abstract][Full Text] [Related]
26. Increased cholesterol efflux capacity in metabolic syndrome: Relation with qualitative alterations in HDL and LCAT.
Lucero D; Sviridov D; Freeman L; López GI; Fassio E; Remaley AT; Schreier L
Atherosclerosis; 2015 Sep; 242(1):236-42. PubMed ID: 26232163
[TBL] [Abstract][Full Text] [Related]
27. Increased 27-hydroxycholesterol plasma level in men with low high density lipoprotein-cholesterol may circumvent their reduced cell cholesterol efflux rate.
Nunes VS; Panzoldo NB; Leança CC; Parra ES; Zago VS; da Silva EJ; Cazita PM; Nakandakare ER; de Faria EC; Quintão EC
Clin Chim Acta; 2014 Jun; 433():169-73. PubMed ID: 24657483
[TBL] [Abstract][Full Text] [Related]
28. HDL particle size is a critical determinant of ABCA1-mediated macrophage cellular cholesterol export.
Du XM; Kim MJ; Hou L; Le Goff W; Chapman MJ; Van Eck M; Curtiss LK; Burnett JR; Cartland SP; Quinn CM; Kockx M; Kontush A; Rye KA; Kritharides L; Jessup W
Circ Res; 2015 Mar; 116(7):1133-42. PubMed ID: 25589556
[TBL] [Abstract][Full Text] [Related]
29. Cholesterol trafficking-related serum lipoprotein functions in children with cholesteryl ester storage disease.
Zimetti F; Favari E; Cagliero P; Adorni MP; Ronda N; Bonardi R; Gomaraschi M; Calabresi L; Bernini F; Guardamagna O
Atherosclerosis; 2015 Oct; 242(2):443-9. PubMed ID: 26291497
[TBL] [Abstract][Full Text] [Related]
30. Adiponectin prevents atherosclerosis by increasing cholesterol efflux from macrophages.
Tsubakio-Yamamoto K; Matsuura F; Koseki M; Oku H; Sandoval JC; Inagaki M; Nakatani K; Nakaoka H; Kawase R; Yuasa-Kawase M; Masuda D; Ohama T; Maeda N; Nakagawa-Toyama Y; Ishigami M; Nishida M; Kihara S; Shimomura I; Yamashita S
Biochem Biophys Res Commun; 2008 Oct; 375(3):390-4. PubMed ID: 18703020
[TBL] [Abstract][Full Text] [Related]
31. Determinants of cholesterol efflux capacity in humans.
Talbot CPJ; Plat J; Ritsch A; Mensink RP
Prog Lipid Res; 2018 Jan; 69():21-32. PubMed ID: 29269048
[TBL] [Abstract][Full Text] [Related]
32. Advanced glycation end-products (AGEs) and functionality of reverse cholesterol transport in patients with type 2 diabetes and in mouse models.
Low H; Hoang A; Forbes J; Thomas M; Lyons JG; Nestel P; Bach LA; Sviridov D
Diabetologia; 2012 Sep; 55(9):2513-21. PubMed ID: 22572804
[TBL] [Abstract][Full Text] [Related]
33. Cholesterol efflux capacity, carotid atherosclerosis, and cerebrovascular symptomatology.
Doonan RJ; Hafiane A; Lai C; Veinot JP; Genest J; Daskalopoulou SS
Arterioscler Thromb Vasc Biol; 2014 Apr; 34(4):921-6. PubMed ID: 24558111
[TBL] [Abstract][Full Text] [Related]
34. Impact of serum amyloid A on cellular cholesterol efflux to serum in type 2 diabetes mellitus.
Tsun JG; Shiu SW; Wong Y; Yung S; Chan TM; Tan KC
Atherosclerosis; 2013 Dec; 231(2):405-10. PubMed ID: 24267259
[TBL] [Abstract][Full Text] [Related]
35. High-density lipoprotein mediated cellular cholesterol efflux in acute coronary syndromes.
Hafiane A; Jabor B; Ruel I; Ling J; Genest J
Am J Cardiol; 2014 Jan; 113(2):249-55. PubMed ID: 24210679
[TBL] [Abstract][Full Text] [Related]
36. Role of lipases, lecithin:cholesterol acyltransferase and cholesteryl ester transfer protein in abnormal high density lipoprotein metabolism in insulin resistance and type 2 diabetes mellitus.
de Vries R; Borggreve SE; Dullaart RP
Clin Lab; 2003; 49(11-12):601-13. PubMed ID: 14651331
[TBL] [Abstract][Full Text] [Related]
37. A loss-of-function variant in OSBPL1A predisposes to low plasma HDL cholesterol levels and impaired cholesterol efflux capacity.
Motazacker MM; Pirhonen J; van Capelleveen JC; Weber-Boyvat M; Kuivenhoven JA; Shah S; Hovingh GK; Metso J; Li S; Ikonen E; Jauhiainen M; Dallinga-Thie GM; Olkkonen VM
Atherosclerosis; 2016 Jun; 249():140-7. PubMed ID: 27105157
[TBL] [Abstract][Full Text] [Related]
38. Angiopoietin-Like Protein 4 Is a High-Density Lipoprotein (HDL) Component for HDL Metabolism and Function in Nondiabetic Participants and Type-2 Diabetic Patients.
Yang LY; Yu CG; Wang XH; Yuan SS; Zhang LJ; Lang JN; Zhao D; Feng YM
J Am Heart Assoc; 2017 Jun; 6(6):. PubMed ID: 28645936
[TBL] [Abstract][Full Text] [Related]
39. High-Density Lipoprotein (HDL) Phospholipid Content and Cholesterol Efflux Capacity Are Reduced in Patients With Very High HDL Cholesterol and Coronary Disease.
Agarwala AP; Rodrigues A; Risman M; McCoy M; Trindade K; Qu L; Cuchel M; Billheimer J; Rader DJ
Arterioscler Thromb Vasc Biol; 2015 Jun; 35(6):1515-9. PubMed ID: 25838421
[TBL] [Abstract][Full Text] [Related]
40. The lipid triad in type 2 diabetes - prevalence and relevance of hypertriglyceridaemia/low high-density lipoprotein syndrome in type 2 diabetes.
Temelkova-Kurktschiev T; Hanefeld M
Exp Clin Endocrinol Diabetes; 2004 Feb; 112(2):75-9. PubMed ID: 15031770
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
